Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

There is evidence of reduced SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. We hypothesized that tumor and treatment-related immunosuppression can be depicted in peripheral blood, and that immune profiling prior to vaccination can help predict immunogenicity. We perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamariz-Amador, Luis-Esteban, Battaglia, Anna Martina, Maia, Catarina, Zherniakova, Anastasiia, Guerrero, Camila, Zabaleta, Aintzane, Burgos, Leire, Botta, Cirino, Fortuño, Maria-Antonia, Grande, Carlos, Manubens, Andrea, Arguiñano, Jose-Maria, Gomez, Clara, Perez-Persona, Ernesto, Olazabal, Iñigo, Oiartzabal, Itziar, Panizo, Carlos, Prosper, Felipe, San-Miguel, Jesus F., Rodriguez-Otero, Paula, Martín-Sánchez, Esperanza, Paiva, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669666/
https://www.ncbi.nlm.nih.gov/pubmed/34907159
http://dx.doi.org/10.1038/s41408-021-00594-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669666/
https://www.ncbi.nlm.nih.gov/pubmed/34907159
http://dx.doi.org/10.1038/s41408-021-00594-1

Ejemplares similares